
The U.S. government could impose more than $11.2 million in fines on companies and universities for failing to report study results on ClinicalTrials.gov, but has so far failed to do so, according to a recently launched website.
Consequently, the folks behind the new site, which is called Trials Tracker, want FDA Commissioner Scott Gottlieb to start levying the $10,000-a-day fines that are permitted under federal law and are adding up each day. Trial sponsors have 13 months from completing a study to posting summary result and side effect information, according to the FDA Amendments Act of 2007.
What is it?
STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.
What's included?
- Daily reporting and analysis
- The most comprehensive industry coverage from a powerhouse team of reporters
- Subscriber-only newsletters
- Daily newsletters to brief you on the most important industry news of the day
- STAT+ Conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
- Exclusive industry events
- Premium access to subscriber-only networking events around the country
- The best reporters in the industry
- The most trusted and well-connected newsroom in the health care industry
- And much more
- Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
And the FDA was mistaken? “Say it ain’t so, Joe!!”
Uh, make that “Ed” …..